PTC THERAPEUTICS, INC. - Director's Dealing 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-06-11

Reporting Person: Smith Mary L. (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-11	Common Stock	A	1650	—	Acquired	1650	Direct
2021-06-11	Common Stock	A	963	—	Acquired	2613	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-11	Stock Option (Right to Buy)	$42.95	A	10000	Acquired	2031-06-10	Common Stock (10000)	Direct
2021-06-11	Stock Option (Right to Buy)	$42.95	A	5834	Acquired	2031-06-10	Common Stock (5834)	Direct

F1: Restricted stock units granted on June 11, 2021 that vest in three equal installments over three years, commencing on June 8, 2022.

F2: Restricted stock units granted on June 11, 2021 that vest on January 6, 2022.

F3: This option was granted on June 11, 2021 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2021.

F4: This option was granted on June 11, 2021 and vests over seven approximately equal monthly installments, commencing on July 6, 2021.